Apatinib mesylate

Overview

Apatinib mesylate is an orally bioavailable, small-molecule receptor tyrosine kinase inhibitor with potential antiangiogenic and antineoplastic activities. Apatinib selectively binds to and inhibits vascular endothelial growth factor receptor 2, which may inhibit VEGF-stimulated endothelial cell migration and proliferation and decrease tumor microvessel density. In addition, this agent mildly inhibits c-Kit and c-SRC tyrosine kinases.

Application

Products > Drug Discovery > Inhibitor | Products > Drug Discovery > Inhibitor | Cancer | VEGFR

Product Information

• Catalog No.: B2693-457664
• CAS No.: 1218779-75-9
• Molecular Formula: C25H27N5O4S
• Molecular Weight: 493.58
• Purity: >98%
• Storage: 2 - 8 °C, keep away from light.

Source

Original product source